ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
RANIBIZUMABUM
Active substance (INN) · ATC S01LA04 · 4 products authorised in Romania
1
Protocols it appears in
As a medicine of the protocol (in the title) or only mentioned in the text
| Code | Protocol | Status | Role | Sublist | GP |
|---|---|---|---|---|---|
| S01LA04 | RANIBIZUMABUM | In force | medicine of the protocol | C1-G26 | NO |
2
Authorised brand products (ANMDM)
The Romanian register of medicines for human use, updated daily
| Brand name | Form | Strength | Holder | ATC | Rx |
|---|---|---|---|---|---|
| BYOOVIZ 10 mg/ml | SOL INJ. | 10mg/ml | SAMSUNG BIOEPIS NL B.V. - OLANDA | S01LA04 | PR |
| RANIVISIO 10 mg/ml | SOL. INJ. | 10mg/ml | MIDAS PHARMA GMBH - GERMANIA | S01LA04 | PR |
| RANIVISIO 10 mg/ml | SOL. INJ. IN SERINGA PREUMPLUTA | 10mg/ml | MIDAS PHARMA GMBH - GERMANIA | S01LA04 | PR |
| RANLUSPEC | SOL INJ. | 10mg/ml | LUPIN EUROPE GMBH - GERMANIA | S01LA04 | PR |
| RANLUSPEC | SOL INJ. IN SERINGA PREUMPLUTA | 10mg/ml | LUPIN EUROPE GMBH - GERMANIA | S01LA04 | PR |
| XIMLUCI 10 mg/ml | SOL. INJ. | 10mg/ml | STADA ARZNEIMITTEL AG - GERMANIA | S01LA04 | PR |